MedPath
NMPA Approval

Larotrectinib Sulfate Oral Solution

国药准字HJ20220056

BAYER AG

June 23, 2022

Drug Information

硫酸拉罗替尼口服溶液

口服溶液剂

50ml:1.0g(按C₂₁H₂₂F₂N₆O₂计)

化学药品

June 23, 2022

June 22, 2027

Company Information

Applicant Company

BAYER AG

51368 Leverkusen, Germany

Manufacturing Company

Units 23-24, Tafarnaubach Industrial Estate, Gwent,Tredegar, NP22 3AA, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath